J-Pharma Co., Ltd. (TYO:520A)
Japan flag Japan · Delayed Price · Currency is JPY
336.00
+1.00 (0.30%)
Nov 18, 2026, 10:40 AM JST

J-Pharma Ratios and Metrics

Millions JPY. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24
6,06912,998--
Market Cap Growth
----
Enterprise Value
2,34110,696--
Last Close Price
335.00729.00--

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24
PB Ratio
1.402.97--
P/TBV Ratio
1.402.97--

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24
Net Debt / Equity Ratio
-1.02-1.02-0.97-1.13
Net Debt / EBITDA Ratio
1.201.201.440.62
Net Debt / FCF Ratio
1.981.981.360.76
Quick Ratio
11.9011.905.135.49
Current Ratio
12.5712.576.285.96
Return on Equity (ROE)
-73.01%-73.01%-90.09%-
Return on Assets (ROA)
-60.88%-60.88%-49.08%-
Return on Capital Employed (ROCE)
-84.60%-84.60%-66.40%-171.00%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24
Earnings Yield
-58.06%-18.98%--
FCF Yield
-36.79%-17.33%--
Buyback Yield / Dilution
--55.23%-29.92%-